Ñî¹óåú´«Ã½

Statement attributable to:
Jacqueline W. Fincher, MD, MACP
President, Ñî¹óåú´«Ã½ 

PHILADELPHIA, March 10, 2021 – The Ñî¹óåú´«Ã½ (ACP) is providing financial support to Project N95 in an effort to ensure personal protective equipment (PPE) is available for frontline ACP members and internists and other frontline healthcare workers. ACP’s financial contribution will help Project N95 to secure appropriate inventory levels for PPE, particularly for hard-to-obtain items such as nitrile gloves.

External URL ACP Lastest Link Type Journal Name

External URL ACP Lastest Link Type Journal Name

PHILADELPHIA, PA, March 2, 2021--The Ñî¹óåú´«Ã½ (ACP) supports the interim recommendation of the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) for the use of the COVID-19 vaccine from Johnson & Johnson through its wholly-owned subsidiary, Janssen, in persons 18 and older in the U.S. under the Food and Drug Administration’s Emergency Use Authorization.

External URL ACP Lastest Link Type Journal Name

External URL ACP Lastest Link Type Journal Name

External URL ACP Lastest Link Type Journal Name

External URL ACP Lastest Link Type Journal Name

WASHINGTON, Feb. 10 — The Ñî¹óåú´«Ã½ (ACP) signaled its strong support for provisions in the COVID relief legislation prepared by two congressional committees to increase access to health care services and health insurance coverage and combat the COVID-19 pandemic.